Elena TantardiniUniversity of Zurich | UZH · Department of quantitative biomedicine
Elena Tantardini
PharmD and PhD student
Investigating molecular pathophysiology ALS and FTD focusing on Fused in Sarcoma protein (FUS) and RNA homeostasis.
About
13
Publications
4,384
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
417
Citations
Introduction
I am PhD student currently working in Polymenidou's laboratory at UZH, Zurich.
Our lab is interested in the pathophysiological roles of two RNA-binding proteins, TDP-43 and FUS, which are possibilty involved in the onset of ALS and FTD.
Specifically, I am investigating the role of FUS in neuronal RNAs homeostasis and synaptic integrity.
Additional affiliations
January 2019 - present
October 2016 - September 2018
Position
- Master's Student
Education
October 2010 - April 2016
Publications
Publications (13)
Human cellular models of neurodegeneration require reproducibility and longevity, which is necessary for simulating age-dependent diseases. Such systems are particularly needed for TDP-43 proteinopathies¹, which involve human-specific mechanisms2–5 that cannot be directly studied in animal models. Here, to explore the emergence and consequences of...
Aggregation of the RNA-binding protein TAR DNA-binding protein 43 (TDP-43) is the key neuropathological feature of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). In physiological conditions, TDP-43 is predominantly nuclear, forms oligomers, and is contained in biomolecular con...
Aggregation of the RNA-binding protein TDP-43 is the main common neuropathological feature of TDP-43 proteinopathies. In physiological conditions, TDP-43 is predominantly nuclear and contained in biomolecular condensates formed via liquid-liquid phase separation (LLPS). However, in disease, TDP-43 is depleted from these compartments and forms cytop...
Aggregation of the RNA-binding protein TDP-43 is the main common neuropathological feature of TDP-43 proteinopathies. In physiological conditions, TDP-43 is predominantly nuclear and contained in biomolecular condensates formed via liquid-liquid phase separation (LLPS). However, in disease, TDP-43 is depleted from these compartments and forms cytop...
While the initial pathology of Parkinson's disease and other α-synucleinopathies is often confined to circumscribed brain regions, it can spread and progressively affect adjacent and distant brain locales. This process may be controlled by cellular receptors of α-synuclein fibrils, one of which was proposed to be the LAG3 immune checkpoint molecule...
Mutations disrupting the nuclear localization of the RNA-binding protein FUS characterize a subset of amyotrophic lateral sclerosis patients (ALS-FUS). FUS regulates nuclear RNAs, but its role at the synapse is poorly understood. Using super-resolution imaging we determined that the localization of FUS within synapses occurs predominantly near the...
While the initial pathology of Parkinson's disease and other α-synucleinopathies is often confined to circumscribed brain regions, it can spread and progressively affect adjacent and distant brain locales. This process may be controlled by cellular receptors of α-synuclein fibrils, one of which was proposed to be the LAG3 immune checkpoint molecule...
While the initial pathology of Parkinson’s disease and other α-synucleinopathies is often confined to circumscribed brain regions, it can spread and progressively affect adjacent and distant brain locales. This process may be controlled by cellular receptors of α-synuclein fibrils, one of which was proposed to be the LAG3 immune checkpoint molecule...
FUS is a primarily nuclear RNA-binding protein with important roles in RNA processing and transport. FUS mutations disrupting its nuclear localization characterize a subset of amyotrophic lateral sclerosis (ALS-FUS) patients, through an unidentified pathological mechanism. FUS regulates nuclear RNAs, but its role at the synapse is poorly understood...
FUS is a primarily nuclear RNA-binding protein with important roles in RNA processing and transport. FUS mutations disrupting its nuclear localization characterize a subset of amyotrophic lateral sclerosis (ALS-FUS) patients, through an unidentified pathological mechanism. FUS regulates nuclear RNAs, but its role at the synapse is poorly understood...
In the version of this Article originally published, the affiliations for Roland A. Fleck and José Antonio Del Río were incorrect due to a technical error that resulted in affiliations 8 and 9 being switched. The correct affiliations are: Roland A. Fleck:8Centre for Ultrastructural Imaging, Kings College London, London, UK. José Antonio Del Río:2Ce...
Reactive oxygen species (ROS) contribute to tissue damage and remodelling mediated by the inflammatory response after injury. Here we show that ROS, which promote axonal dieback and degeneration after injury, are also required for axonal regeneration and functional recovery after spinal injury. We find that ROS production in the injured sciatic ner...
Questions
Questions (4)
I aim to culture motoneurons from spinal cord.
what is the best protocol to get healthy motoneuorns? should I culture from embrios or p0/p1 mice are good enough?
what-s the right medium I have to use? does the medium have to contain factors? if yes, which ones and why? thank you!
Hello,
i am culturing adult (p20)DRGs neurons in compartmentalized microfluidich chambers (XONA 450um).
I plate 100k or 150k cells in channel.
after 48 they have completely crossed the barrier and the axons are sprouting in the axonal part.
unfortunately after 10-12 days of culture axons degenerate (they show the dotted pattern).
the medium is the following:
-neurobasal
-p/s
-b27 without vit A 2%
and i add also GDNF, BDNF and CTNF.
thank you in advance!
I want to see by IF APC and I want the antibody to mark the C-terminus since I am planning to see his co-localization with actin and microtubules..
thank you! :-)
Hello everybody,
I have problem with my cell culture of retinal cells.
I take retinas from P9-P12 mice and I dissociated them following the protocol attached.
I have the 7% of alive cells maximum (checked with Trypan Blue).